DOI QR코드

DOI QR Code

Elevated Cellular Retinoic Acid Binding Protein-I in Cerebrospinal Fluid of Patients with Hemorrhagic Cerebrovascular Diseases : Preliminary Study

  • Jeon, Jin Pyeong (Department of Neurosurgery, Hallym University College of Medicine) ;
  • Cho, Won-Sang (Department of Neurosurgery, Seoul National University College of Medicine) ;
  • Kang, Hyun-Seung (Department of Neurosurgery, Seoul National University College of Medicine) ;
  • Kim, Jeong Eun (Department of Neurosurgery, Seoul National University College of Medicine) ;
  • Kim, Seung-Ki (Department of Neurosurgery, Seoul National University College of Medicine) ;
  • Oh, Chang Wan (Department of Neurosurgery, Seoul National University College of Medicine)
  • 투고 : 2014.06.26
  • 심사 : 2014.09.15
  • 발행 : 2015.02.28

초록

Objective : Elevated cellular retinoic acid binding protein-I (CRABP-I) is thought to be related to the abnormal proliferation and migration of smooth muscle cells (SMCs). Accordingly, a higher CRABP-I level could cause disorganized vessel walls by causing immature SMC phenotypes and altering extracellular matrix proteins which could result in vulnerable arterial walls with inadequate responses to hemodynamic stress. We hypothesized that elevated CRABP-I level in the cerebrospinal fluid (CSF) could be related to subarachnoid hemorrhage (SAH). Moreover, we also extended this hypothesis in patients with vascular malformation according to the presence of hemorrhage. Methods : We investigated the CSF of 26 patients : SAH, n=7; unruptured intracranial aneurysm (UIA), n=7; arteriovenous malformation (AVM), n=4; cavernous malformation (CM), n=3; control group, n=5. The optical density of CRABP-I was confirmed by Western blotting and presented as mean${\pm}$standard error of the measurement. Results : CRABP-I in SAH ($0.33{\pm}0.09$) was significantly higher than that in the UIA ($0.12{\pm}0.01$, p=0.033) or control group ($0.10{\pm}0.01$, p=0.012). Hemorrhage presenting AVM (mean 0.45, ranged 0.30-0.59) had a higher CRABP-I level than that in AVM without hemorrhage presentation (mean 0.16, ranged 0.14-0.17). The CRABP-I intensity in CM with hemorrhage was 0.21 and 0.31, and for CM without hemorrhage 0.14. Overall, the hemorrhage presenting group (n=11, $0.34{\pm}0.06$) showed a significantly higher CRABP-I intensity than that of the non-hemorrhage presenting group (n= 10, $0.13{\pm}0.01$, p=0.001). Conclusion : The results suggest that elevated CRABP-I in the CSF could be related with aneurysm rupture. Additionally, a higher CRABP-I level seems to be associated with hemorrhage development in vascular malformation.

키워드

참고문헌

  1. Astrom A, Pettersson U, Chambon P, Voorhees JJ : Retinoic acid induction of human cellular retinoic acid-binding protein-II gene transcription is mediated by retinoic acid receptor-retinoid X receptor heterodimers bound to one far upstream retinoic acid-responsive element with 5-base pair spacing. J Biol Chem 269 : 22334-22339, 1994
  2. Axel DI, Frigge A, Dittmann J, Runge H, Spyridopoulos I, Riessen R, et al. : All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovasc Res 49 : 851-862, 2001 https://doi.org/10.1016/S0008-6363(00)00312-6
  3. Bauters C, Marotte F, Hamon M, Oliviero P, Farhadian F, Robert V, et al. : Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries. Circulation 92 : 904-911, 1995 https://doi.org/10.1161/01.CIR.92.4.904
  4. Boylan JF, Gudas LJ : The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J Biol Chem 267 : 21486-21491, 1992
  5. Bruno G, Todor R, Lewis I, Chyatte D : Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg 89 : 431-440, 1998 https://doi.org/10.3171/jns.1998.89.3.0431
  6. Bygglin H, Laaksamo E, Myllarniemi M, Tulamo R, Hernesniemi J, Niemela M, et al. : Isolation, culture, and characterization of smooth muscle cells from human intracranial aneurysms. Acta Neurochir (Wien) 153 : 311-318, 2001
  7. DeRose JJ Jr, Madigan J, Umana JP, Prystowsky JH, Nowygrod R, Oz MC, et al. : Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc Surg 7 : 633-639, 1999 https://doi.org/10.1016/S0967-2109(99)00041-1
  8. Jeon JS, Ahn JH, Moon YJ, Cho WS, Son YJ, Kim SK, et al. : Expression of cellular retinoic acid-binding protein-I (CRABP-I) in the cerebrospinal fluid of adult onset moyamoya disease and its association with clinical presentation and postoperative haemodynamic change. J Neurol Neurosurg Psychiatry 85 : 726-731, 2014 https://doi.org/10.1136/jnnp-2013-305953
  9. Kam RK, Deng Y, Chen Y, Zhao H : Retinoic acid synthesis and functions in early embryonic development. Cell Biosci 2 : 11, 2012 https://doi.org/10.1186/2045-3701-2-11
  10. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PM : Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46 : 1179-1191; discussion 1191-1192, 2000 https://doi.org/10.1097/00006123-200005000-00032
  11. Kilic T, Sohrabifar M, Kurtkaya O, Yildirim O, ElmaciI, Gunel M, et al. : Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls. Neurosurgery 57 : 997-1007; discussion 997-1007, 2005 https://doi.org/10.1227/01.NEU.0000180812.77621.6C
  12. Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, et al. : Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease. Stroke 34 : 2835-2841, 2003 https://doi.org/10.1161/01.STR.0000100159.43123.D7
  13. Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H : Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 29 : 181-188; discussion 189, 1998 https://doi.org/10.1161/01.STR.29.1.181
  14. Miano JM, Topouzis S, Majesky MW, Olson EN : Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation 93 : 1886-1895, 1996 https://doi.org/10.1161/01.CIR.93.10.1886
  15. Neuville P, Yan Z, Gidlof A, Pepper MS, Hansson GK, Gabbiani G, et al. : Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. Arterioscler Thromb Vasc Biol 19 : 1430-1436, 1999 https://doi.org/10.1161/01.ATV.19.6.1430
  16. Patel MK, Lymn JS, Clunn GF, Hughes AD : Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17 : 2107-2114, 1997 https://doi.org/10.1161/01.ATV.17.10.2107
  17. Rensen SS, Doevendans PA, van Eys GJ : Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15 : 100-108, 2007 https://doi.org/10.1007/BF03085963
  18. Riessen R, Kearney M, Lawler J, Isner JM : Immunolocalization of thrombospondin- 1 in human atherosclerotic and restenotic arteries. Am Heart J 135 (2 Pt 1) : 357-364, 1998 https://doi.org/10.1016/S0002-8703(98)70105-X
  19. Uranishi R, Baev NI, Kim JH, Awad IA : Vascular smooth muscle cell differentiation in human cerebral vascular malformations. Neurosurgery 49 : 671-679; discussion 679-680, 2001
  20. van der Loop FT, Schaart G, Timmer ED, Ramaekers FC, van Eys GJ : Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 134 : 401-411, 1996 https://doi.org/10.1083/jcb.134.2.401
  21. Varani J, Mitra RS, Gibbs D, Phan SH, Dixit VM, Mitra R Jr, et al. : Alltrans retinoic acid stimulates growth and extracellular matrix production in growth-inhibited cultured human skin fibroblasts. J Invest Dermatol 94 : 717-723, 1990 https://doi.org/10.1111/1523-1747.ep12876294
  22. Zempo N, Kenagy RD, Au YP, Bendeck M, Clowes MM, Reidy MA, et al. : Matrix metalloproteinases of vascular wall cells are increased in balloon- injured rat carotid artery. J Vasc Surg 20 : 209-217, 1994 https://doi.org/10.1016/0741-5214(94)90008-6